Skip to content

Study · Not a test of the peptide alone · 2024

5 results

Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples.

Thomas A, Walpurgis K, Thevis M

Journal of mass spectrometry : JMS1 Jan 2024Cited by 4 (Europe PMC)

PMID38197510 (opens in a new tab)DOI10.1002/jms.4996 (opens in a new tab)PepBankPUB-38197510
Read at sourcePubMedAsk about this study
Jump to 5 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study5

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone5

In this study, the peptide was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking the peptide.

  1. 01LabNot a test of CJC-1295 (with DAC) aloneOther designOther

    A validated mass spectrometric method with a generic extraction detected CJC‑1295 and its metabolites in doping control urine samples.

    In plain wordsIn lab tests, one validated method could detect CJC‑1295 and its metabolites in urine samples taken for doping control.

    Peptide
    CJC-1295 (with DAC)
    Outcome
    Not applicableDetection in doping control urine by a validated method
    Study

    n: not reported in source

    Doping control urine samples
    Outcome group
    Analytical methods and detection · Pharmacology

    Source sentences

    Summary
    growth hormone-releasing hormones (sermorelin, CJC-1295, tesamorelin) incl. their respective metabolites
    1 context sentence
    Summary · context
    Nearly all requirements of the recent technical documents from the World Anti-Doping Agency (WADA) considering their minimum required performance levels (MRPL) are fulfilled, and the method was validated for its utilisation as initial testing procedure in doping controls.

    In this study, CJC-1295 (with DAC) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking CJC-1295 (with DAC).

  2. 02LabNot a test of Tesamorelin aloneOther designOther

    A validated mass spectrometric method with a generic extraction detected tesamorelin and its metabolites in doping control urine samples.

    In plain wordsIn lab tests, one validated method could detect tesamorelin and its metabolites in urine samples taken for doping control.

    Peptide
    Tesamorelin
    Outcome
    Not applicableDetection in doping control urine by a validated method
    Study

    n: not reported in source

    Doping control urine samples
    Outcome group
    Analytical methods and detection · Pharmacology

    Source sentences

    Summary
    growth hormone-releasing hormones (sermorelin, CJC-1295, tesamorelin) incl. their respective metabolites
    1 context sentence
    Summary · context
    Nearly all requirements of the recent technical documents from the World Anti-Doping Agency (WADA) considering their minimum required performance levels (MRPL) are fulfilled, and the method was validated for its utilisation as initial testing procedure in doping controls.

    In this study, Tesamorelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Tesamorelin.

  3. 03LabNot a test of Sermorelin aloneOther designOther

    A chromatographic-mass spectrometric method for peptides of 2-10 kDa in doping control urine, including sermorelin, met nearly all WADA minimum required performance levels and was validated for initial testing.

    In plain wordsA lab method for finding sermorelin and other peptides in urine met almost all anti-doping performance requirements.

    Peptide
    Sermorelin
    Outcome
    Not applicableMethod validation against WADA performance levels
    Study

    n: not reported in source

    Outcome group
    Analytical methods and detection · Pharmacology

    Source sentences

    Summary
    Nearly all requirements of the recent technical documents from the World Anti-Doping Agency (WADA) considering their minimum required performance levels (MRPL) are fulfilled, and the method was validated for its utilisation as initial testing procedure in doping controls.
    1 context sentence
    Summary · context
    efficient extraction of peptidic analytes from this matrix was a major goal of this method

    In this study, Sermorelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Sermorelin.

  4. 04LabNot a test of MGF / PEG-MGF aloneOther designOther

    A method for efficient extraction of 2-10 kDa peptidic analytes from urine was demonstrated for compounds including human MGF and MGF-Goldspink.

    In plain wordsIn lab tests, a method extracted many peptide drugs, including MGF forms, from urine samples for doping control.

    Peptide
    MGF / PEG-MGF
    Outcome
    Not applicableExtraction of peptides including MGF from doping control urine
    Study

    n: not reported in source

    Outcome group
    Analytical methods and detection · Pharmacology

    Source sentences

    Summary
    efficient extraction of peptidic analytes from this matrix
    1 context sentence
    Summary · context
    mechano growth factors (human MGF, MGF-Goldspink

    In this study, MGF / PEG-MGF was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking MGF / PEG-MGF.

  5. 05LabNot a test of MGF / PEG-MGF aloneOther designOther

    The multi-peptide method, which includes MGF forms, met nearly all WADA minimum required performance levels and was validated as an initial test in doping controls.

    In plain wordsIn lab tests, the method met almost all anti-doping performance requirements for the peptides it covers, including MGF forms.

    Peptide
    MGF / PEG-MGF
    Outcome
    Not applicableMethod validation against WADA minimum required performance levels
    Study

    n: not reported in source

    Outcome group
    Analytical methods and detection · Pharmacology

    Source sentences

    Summary
    Nearly all requirements of the recent technical documents from the World Anti-Doping Agency (WADA) considering their minimum required performance levels (MRPL) are fulfilled, and the method was validated for its utilisation as initial testing procedure in doping controls.

    In this study, MGF / PEG-MGF was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking MGF / PEG-MGF.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Versions 25 to 48Current

    28 Oct 2026, 02:04 UTC

    The same notice was added 24 times, first on 13 Oct 2026, 21:43 UTC. The status did not change between them.

    Study results updated

  2. Version 24

    13 Oct 2026, 16:31 UTC

    Study data updated · source update from Europe PMC

  3. Versions 4 to 23

    13 Oct 2026, 14:22 UTC

    The same notice was added 20 times, first on 9 Oct 2026, 18:17 UTC. The status did not change between them.

    Study results updated

  4. Versions 2 to 3

    9 Oct 2026, 03:13 UTC

    The same notice was added 2 times, first on 9 Oct 2026, 03:13 UTC. The status did not change between them.

    Study data updated · source update from Europe PMC

  5. Version 1

    9 Oct 2026, 03:13 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.